News

DSC127 is a novel angiotensin analog, which has been shown to improve epithelialisation, granulation, vascularisation, and accelerate wound healing in a variety of normal and diabetic animal models.

The patch is scheduled to be marketed under the trademark TETRACAN, and will be available at medical marijuana dispensaries by the end of 2011 across the US. It

The purchase price is $30 per share in cash plus contingent consideration of up to $6 per share that may be paid upon achievement of certain commercial milestones

Alpha Biologics is a contract process development and GMP bio-manufacturing company. It has process development laboratories located in the biotech cluster of Cambridge, UK and a GMP mammalian

Calistoga could earn up to an additional $225m if certain milestones are achieved. Calistoga’s lead product candidate, CAL-101, is a first-in-class specific inhibitor of the PI3K delta isoform.

PENTASA is indicated for the treatment of ulcerative colitis, proctitis, proctosigmoiditis, and also to prevent the symptoms of ulcerative colitis from recurring. At per Shire’s request, preparations are

iCo is evaluating potential clinical activities in several regulatory jurisdictions, including Canada, where it has received a No Objection Letter from Health Canada’s Therapeutic Products Directorate related to

Sun Pharma Global is a wholly-owned subsidiary of Sun Pharma organized under the laws of the British Virgin Islands (Sun Global) and a newly-formed, indirect wholly-owned subsidiary of

The agreement will promote cooperative efforts for joint technical review of Wi-Fi Alliance and Continua Health Alliance specifications and guidelines. The idea is to facilitate interoperability of personal